Dalriada is a small molecule drug discovery company supporting global innovators through its TURN-KEY™ model, where R&D is perfectly aligned with business and IP. With all R&D operations in Mississauga, Canada, we build focused expert teams in MedChem, Biology and ADME to allow for the most rapid project advancements and value building. Continuing to innovate alongside start-ups and billion-dollar companies…
Company Details
- Employees
- 48
- Founded
- -
- Address
- 2820 Argentia Rd, Mississauga,ontario L5n 8g4,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dalriadatx.com
- Keywords
- drug discovery, drug development, anti-cancer therapeutics, pharmaceutical R&D, medicinal chemistry.
- HQ
- Mississauga, Ontario
Dalriada Drug Discovery Questions
Dalriada Drug Discovery's website is dalriadatx.com
Dalriada Drug Discovery's LinkedIn profile is https://ca.linkedin.com/company/dalriada-drug-discovery
Dalriada Drug Discovery has
48 employees.
View email and phone details for 48
employees at Dalriada Drug Discovery.
Dalriada Drug Discovery's industry is
Biotechnology Research
Dalriada Drug Discovery's top competitors are
Ripple Therapeutics,
Noa Therapeutics,
Ccrm,
Paradox Immunotherapeutics,
Dalton Pharma Services,
Dunad Therapeutics,
Paraza Pharma Inc.,
Bluerock Therapeutics,
Hdax Therapeutics,
Omniabio.
Dalriada Drug Discovery's categories are Biotechnology Research
Dalriada Drug Discovery's founding year is 2017
